Affected by 63I-2-236 on 12/31/2023
Effective 5/4/2022
36-29-301. Definitions.
As used in this part:
- (1) “Department” means the Department of Health and Human Services created in Section 26B-1-201.
- (2) “Executive director” means the executive director of the department.
- (3) “Psychotherapy drug” means a controlled substance that:
- (a) is not currently available for legal use; and
- (b) may be able to treat, manage, or alleviate symptoms from mental illness.
- (4) “Task force” means the Mental Illness Psychotherapy Drug Task Force created in this part.
Enacted by Chapter 141, 2022 General Session